| pubmed-article:9294627 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9294627 | lifeskim:mentions | umls-concept:C0031330 | lld:lifeskim |
| pubmed-article:9294627 | lifeskim:mentions | umls-concept:C1522642 | lld:lifeskim |
| pubmed-article:9294627 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
| pubmed-article:9294627 | lifeskim:mentions | umls-concept:C0257343 | lld:lifeskim |
| pubmed-article:9294627 | lifeskim:mentions | umls-concept:C2003941 | lld:lifeskim |
| pubmed-article:9294627 | lifeskim:mentions | umls-concept:C0679932 | lld:lifeskim |
| pubmed-article:9294627 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:9294627 | lifeskim:mentions | umls-concept:C0449560 | lld:lifeskim |
| pubmed-article:9294627 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:9294627 | pubmed:dateCreated | 1997-10-9 | lld:pubmed |
| pubmed-article:9294627 | pubmed:abstractText | alpha 1-adrenergic receptors (alpha 1 ARs) are important in the dynamic component of benign prostatic hyperplasia (BPH). Currently, several alpha 1AR antagonists are being used in the treatment of BPH. | lld:pubmed |
| pubmed-article:9294627 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9294627 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9294627 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9294627 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9294627 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9294627 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9294627 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9294627 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9294627 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9294627 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9294627 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9294627 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9294627 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9294627 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:9294627 | pubmed:issn | 0270-4137 | lld:pubmed |
| pubmed-article:9294627 | pubmed:author | pubmed-author:WilsonK HKH | lld:pubmed |
| pubmed-article:9294627 | pubmed:author | pubmed-author:DonatucciC... | lld:pubmed |
| pubmed-article:9294627 | pubmed:author | pubmed-author:RichardsonC... | lld:pubmed |
| pubmed-article:9294627 | pubmed:author | pubmed-author:SchwinnD ADA | lld:pubmed |
| pubmed-article:9294627 | pubmed:author | pubmed-author:PageS OSO | lld:pubmed |
| pubmed-article:9294627 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9294627 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:9294627 | pubmed:volume | 33 | lld:pubmed |
| pubmed-article:9294627 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9294627 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9294627 | pubmed:pagination | 55-9 | lld:pubmed |
| pubmed-article:9294627 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:9294627 | pubmed:meshHeading | pubmed-meshheading:9294627-... | lld:pubmed |
| pubmed-article:9294627 | pubmed:meshHeading | pubmed-meshheading:9294627-... | lld:pubmed |
| pubmed-article:9294627 | pubmed:meshHeading | pubmed-meshheading:9294627-... | lld:pubmed |
| pubmed-article:9294627 | pubmed:meshHeading | pubmed-meshheading:9294627-... | lld:pubmed |
| pubmed-article:9294627 | pubmed:meshHeading | pubmed-meshheading:9294627-... | lld:pubmed |
| pubmed-article:9294627 | pubmed:meshHeading | pubmed-meshheading:9294627-... | lld:pubmed |
| pubmed-article:9294627 | pubmed:meshHeading | pubmed-meshheading:9294627-... | lld:pubmed |
| pubmed-article:9294627 | pubmed:meshHeading | pubmed-meshheading:9294627-... | lld:pubmed |
| pubmed-article:9294627 | pubmed:meshHeading | pubmed-meshheading:9294627-... | lld:pubmed |
| pubmed-article:9294627 | pubmed:meshHeading | pubmed-meshheading:9294627-... | lld:pubmed |
| pubmed-article:9294627 | pubmed:meshHeading | pubmed-meshheading:9294627-... | lld:pubmed |
| pubmed-article:9294627 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9294627 | pubmed:articleTitle | Pharmacology of tamsulosin: saturation-binding isotherms and competition analysis using cloned alpha 1-adrenergic receptor subtypes. | lld:pubmed |
| pubmed-article:9294627 | pubmed:affiliation | Department of Anesthesiology, Duke University, Durham, North Carolina, USA. | lld:pubmed |
| pubmed-article:9294627 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9294627 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9294627 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9294627 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9294627 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9294627 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9294627 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9294627 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9294627 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9294627 | lld:pubmed |
